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Postoperative Tumor Imaging
Laura W. Bancroft, M.D.1,2,3
ABSTRACT
Accurately interpreting the imaging findings in patients with prior muscu-
loskeletal tumors can be difficult. Because most patients have anatomical changes
related to surgery in addition to postradiation and postchemotherapy changes, the
radiologist must systematically and critically evaluate all available radiographs, sono-
grams, computed tomography, magnetic resonance imaging, and positron emission
tomography/computed tomography scans to best differentiate normal posttreatment
changes from residual or recurrent musculoskeletal tumor. Comparison with presur-
gical and postsurgical imaging is very important to detect subtle nodular tumor
recurrence. Because postoperative fluid collections are relatively common, the radiol-
ogist must be vigilant for any nodular-enhancing foci that are actually residual or
recurrent tumor.
KEYWORDS: Postoperative, MRI, musculoskeletal, tumor
Deciphering the postoperative imaging appear-
ance of the patient with prior musculoskeletal imaging
can be difficult. Patients with a history of treated soft
tissue or osseous tumors often have a combination of
postsurgical, postradiation, and postchemotherapy
changes on their imaging studies. Postoperative alter-
ations in anatomy, fibrosis, edema, and metallic suscept-
ibility artifact can make imaging interpretation complex.
Knowledge of the expected posttreatment changes on
radiographs, sonography, computed tomography (CT),
and magnetic resonance imaging (MRI) is critical to
differentiate this from residual or recurrent musculoske-
letal tumor.
RESECTION
One of the most common treatments for osseous and
soft tissue tumors is surgical resection. Knowledge of
the exact surgical procedure can be helpful to the
radiologist to make the most accurate imaging diag-
nosis. Depending on the histology and behavior of a
particular tumor, different types of surgical margins
are planned. Intralesional margins will leave micro-
scopic evidence of lesion at the margin after debulk-
ing or curetting (Fig. 1). With marginal margins, the
lesion is shelled out (usually within a pseudocapsule)
and no normal tissue is removed. A wide margin is
accomplished when a soft tissue tumor, its pseudo-
capsule, and a cuff of normal tissue peripheral to the
tumor are removed circumferentially en bloc.1 A
radical margin is acquired when tumor and the entire
involved compartment are excised. Malignant osseous
and soft tissue tumors require a wide marginal ex-
cision to minimize risks of residual or recurrent tumor
(Fig. 2).
Radiographs are the most common imaging
modality used to evaluate the initial postsurgical
changes of osseous tumor resection, although recent
postoperative MRIs are often obtained to serve as a
baseline for future comparison. MRI, positron emission
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tomography/computed tomography (PET/CT), en-
hanced CT (if there is a contraindication to MRI or
there is excessive susceptibility artifact from hardware),
or sonography are used for surveillance of soft tissue
lesions. MRI and PET/CT are also useful in the
detection of marrow-replacing tumor recurrences.
LIMB SALVAGE PROCEDURES
Resection of a musculoskeletal tumor without amputa-
tion (limb salvage) can be accomplished in 80% of
patients with sarcomas, and patients generally prefer
this over amputation because of superior function,
cosmetic results, psychological reasons, and other
Figure 1 Aneurysmal bone cyst of C2. (A) Lateral cervical spine radiograph obtained in a 9-year-old boy demonstrates a lytic
lesion in the C2 vertebra that exhibits most expansile remodeling in the posterior elements (arrow). (B) Sagittal two-dimensional
computed tomography reconstruction and (C) three-dimensional surface rendered image from the posterior projection
demonstrate the normal postoperative imaging findings after vertebrectomy and strut graft placement, anterior spinal plate
and screw fixation, C2-3 posterior decompression, and cervicocranial fusion.







































factors.1,2 Resection of the involved segment of bone
may lead to compromised mechanical support; there-
fore, reconstruction with bone grafting, synthetic con-
structs, or metallic fixation may be required. For
example, if a partial sacrectomy is performed for a large
chordoma or chondrosarcoma, the addition of fibular
strut grafts with or without rod fixation may be needed
as part of a two-stage procedure (Figs. 3 and 4).3,4
Cadaveric intercalary and osteoarticular allografts
serve as biological reconstruction after sarcoma resection,
especially in young children.5 These allografts are chosen
preoperatively to nearly replicate the contour and size of
the resected bone, thereby maximizing function
(Fig. 5).5 Allograft-prosthetic composite reconstruction
can also be used for the treatment of osseous tumors.
This technique combines a cadaveric intercalary or
osteoarticular graft with an endoprosthesis, after defin-
itive resection of the tumor (Fig. 6).6,7
Osseous tumor resection and immediate recon-
struction with an endoprosthesis allow patients to
return rapidly to full weightbearing and functional
activities.8 Joint replacement with a megaprosthesis is
almost always performed for a femoral tumor with skip
lesions or massive intramedullary extension of a dia-
physeal sarcoma.9 Total femoral megaprostheses re-
place the hip and knee joints. Complications of
megaprostheses include dislocation, local recurrence,
periprosthetic fracture, and deep infection.9,10 Radio-
graphs are the first imaging modality to evaluate most
of these complications, with higher level imaging added
as needed.
Arthrodesis with large bone grafts or more
unusual types of limb salvage procedures may be
alternatively performed for patients with musculoske-
letal malignancies. Amputation and reimplantation
of the upper extremity have been reported in the
literature.1 Despite gross shortening of the limb,
patients typically have better function compared
with amputation and utilization of an external pros-
thesis.
Figure 2 Internal hemipelvectomy for osteosarcoma. (A) Anteroposterior (AP) radiograph of the right hemipelvis in a 21-year-
old woman with a several month history of right buttock pain demonstrates osteoid mineralization (arrows) about the right
superior and inferior pubic rami. (B) Axial T1-weighted image shows a corresponding lobulated soft tissue mass (asterisks) that
is heterogeneously hyperintense due to osteoid production. (C) AP radiograph of the pelvis after internal hemipelvectomy
demonstrates wide resection of the bilateral pubic bones, right acetabulum, and right proximal femur. Note also the proximal
femoral fixation screws and soft tissue suture anchors in the right lateral iliac wing and left superior pubic ramus.







































Rotationplasty is an uncommon surgical proce-
dure in which the distal femur and knee joint are
resected, the lower leg is rotated 180 degrees, and the
remaining limb is fused. This technique is used to
treat patients with osteosarcoma of the distal femur,
especially in skeletally immature patients; when am-
putation is needed to achieve adequate margins; or
when endoprosthesis placement would result in leg-
length discrepancy from loss of growth.11 In addition,
rotationplasty can be used in patients with failed
reconstructions after resection of tumors around the
knee.12 Although cosmetically deforming, rotation-
plasty is a reasonable alterative to amputation, ar-
throdesis, or endoprosthesis because of its superior
function. Rotationplasty allows active movement of
the knee by the rotated foot with preserved sensa-
tion.12 There are also no problems with neuroma or
phantom pain.12 Because metallic hardware is rarely
used to achieve fixation, there is no susceptibility
artifact limiting the detection of residual or recurrent
tumor (Fig. 7). However, rotationplasty has potential
complications including vascular compromise, patho-
logic fracture, nerve palsy, and wound complica-
tions.13,14
AMPUTATION
When limb-sparing surgery is not an option, amputation
is performed as the definitive treatment of malignant
osseous or a soft tissue tumor. On rare occasions,
aggressive tumors with benign histology (such as des-
moid tumors) can be so infiltrative and painful that
amputation may be the treatment of last resort (Fig. 8).
Imaging may be prompted to evaluate an amputee
with pain. Radiography can be helpful in diagnosing
some postsurgical problems, specifically an aggressive
bone edge, heterotopic ossification, or osteomyelitis.15
In addition, stump neuromas are common in amputees.
Terminal neuromas occur along the distal portion of the
transected nerve after amputation because the proximal
axons grow and form an extremely sensitive bulbous
overgrowth.16 These lesions occur within 1 month to
1 year after amputation, may enlarge for 2 to 3 years, and
can result in stump pain.16 Terminal neuromas are ovoid,
well-defined, or irregularly marginated nodules in direct
continuity with the nerve on sonography, and they are
seen as bulbous expansion of the transected nerve on
MRI or CT (Fig. 9).16 Sonography is useful for the
detection of these lesions, and it serves as image guidance
for percutaneous steroid injection.16
Figure 3 Partial sacrectomy with fibular strut graft placement for chordoma. (A) Sagittal T2-weighted image through the
midsacrum demonstrates a large soft tissue mass (asterisk) emanating from the S3-5 segments and obliterating the coccyx
in this 47-year-old woman with progressive coccygeal pain for 2 to 3 years. (B) Three-dimensional (3D) surface rendered
image obtained after the initial sacral resection delineates the margin of the resection bed. (C) 3D surface rendered image
after the second surgery displays the added fibular strut grafts (arrows) that serve as structural support after partial
sacrectomy.








































Myocutaneous flaps can be used for soft tissue coverage
after the resection of soft tissue malignancy. Flaps are
either free flaps with reanastomosed vascular pedicles or
rotational flaps placed into a soft tissue defect. It is
important to be familiar with the postoperative appear-
ance of myocutaneous flaps so as not to confuse them
with recurrent or residual tumor (Fig. 10). Flaps initially
demonstrate increased T2-weighted signal intensity but
will revert to baseline signal in about a third of pa-
tients.17 Findings are likely related to a combination of
denervation, disuse, and radiation changes (when ad-
ministered). Myocutaneous flap enhancement occurs in
three fourths of patients but typically resolves in one
third of cases within 18 months.17 Myocutaneous flaps
also undergo progressive fatty atrophy.
TUMOR RECURRENCE
Optimal imaging interpretation depends on knowledge
of when a musculoskeletal tumor was resected, histo-
logic tumor grade, and whether or not tumor-free
surgical margins were achieved. Despite abnormal
MR signal in and around the surgical bed in a recently
postoperative patient with negative surgical margins,
imaging support for residual/recurrent tumor is highly
unlikely. Recurrent osseous or soft tissue musculoske-
letal tumors are often detected as rounded or ovoid
Figure 4 Chondrosarcoma sacrectomy with fibular strut grafts. A 53-year-old man presented with a 3-year history of
worsening left leg pain and new back pain radiating to the posterior left thigh and calf weakness. (A) Coronal two-dimensional
reconstruction through the sacrum demonstrates a lytic mass with chondroid mineralization in the S1 and S2 bodies, with
extension into the left-sided wing. Note the destruction of the left S1 neural foramina and obliteration of the involved portion of
the S1 nerve. (B) Radiograph obtained after en bloc excision of the grade 1 chondrosarcoma and staged reconstruction with
fibular allograft, lumbosacral pedicle screw, and iliac fixation.
Figure 5 Distal radial resection, osteochondral allograft,
and Suave-Kapandji procedure for osteosarcoma. Radiograph
of the distal forearm and wrist in a 24-year-old woman shows
bone grafting (arrowhead) and plate and screw fixation
across the distal radial osteochondral allograft (arrows). A
Suave-Kapandji procedure (distal ulnar osteotomy with distal
radioulnar fixation) has also been performed to provide
stabilization of the distal radioulnar joint. Kirschner wires
were temporarily placed for added stabilization.







































nodules, and they often have a similar imaging appear-
ance to the original tumor (Fig. 11). Therefore, direct
comparison with preoperative imaging is very useful in
the detection of early subtle tumor recurrence. The
‘‘muscle texture’’ sign on MR imaging is the presence of
linear or streaks of fat between muscle bundles and
indicates no underlying soft tissue mass to suggest
recurrence (Fig. 12).18,19
If an osseous tumor has been curetted and packed
with bone graft or cement, recurrent tumor most often
recurs along the cement/graft margin (Fig. 13).18 If
available, surveillance MRI is advised in patients after
resection of musculoskeletal sarcoma because 20% of
all sarcomas and 30% of all resected sarcomas with
positive margins recur.1,20 Susceptibility artifact from
metallic fixation may obscure small recurrences on MRI
and CT (Fig. 14), although MRI techniques are avail-
able to decrease artifact such as increasing receiver
bandwidth, increasing matrix size, using fast spin-echo
imaging and avoiding gradient-echo sequences. Sonog-
raphy has proven useful in experienced hands for the
detection of nodular soft tissue recurrence.
Tumor recurrence can usually be differentiated
from postoperative fluid collections such as seromas
and hematomas. Tumor foci are typically round or
ovoid, hypoechoic on sonography, T2 hyperintense on
MRI, and demonstrate internal vascularity on color
flow Doppler imaging and enhancement on MRI.17,21
In contradistinction, seromas are typically anechoic or
hypoechoic, ovoid or irregular, and may contain a dark
pseudocapsule on sonography.21,22 Seromas may dem-
onstrate internal swirling of contents, compressibility,
posterior acoustic enhancement, and lack of internal
vascularity.21,22 However, certain histological types of
tumors can be difficult to distinguish from postoperative
fluid collections, such as recurrent low-grade chondroid
lesions and myxoid sarcomas. The cartilage lobules
within low-grade chondrosarcoma do not enhance, and
only minimal lacelike enhancement may be appreciated
in myxoid lesions such as myxoid liposarcoma and
undifferentiated pleomorphic sarcoma.18 Therefore,
small recurrences may be overlooked and misdiagnosed
as postsurgical fluid collections.
Residual/recurrent benign and malignant fibrous
tumors (i.e., desmoid tumor and fibrosarcoma) have low-
signal intensity components that may be misdiagnosed as
scar tissue on MR imaging.18 In addition, fibrosarcoma
has a tendency to infiltrate beyond the primary tumor
bed, resulting in multifocal, noncontiguous tumor de-
posits.18 Care must be taken in the interpretation of
these postoperative studies not to overlook residual or
recurrent malignancy. In indeterminate cases, image-
guided biopsy or 3- to 6-month imaging follow-up
may be prudent for follow-up.
POSTTREATMENT MARROW CHANGES
Radiation therapy often results in increased yellow
marrow in the irradiated field, with complete replace-
ment of the red marrow on imaging at 6 to 8 weeks
Figure 6 Allograft-prosthetic composite for chondrosarcoma of the femur. (A) Coronal two-dimensional reformatted
computed tomography image of the left proximal femoral chondrosarcoma (arrows) delineates the ‘‘arcs and rings’’ type of
chondroid mineralization, with focal areas of endosteal scalloping (arrowheads) at regions of more aggressive behavior.
(B) Postoperative radiograph shows proximal femoral resection and placement of an allograft (large arrows) bipolar prosthesis
composite graft. Also note the lateral femoral onlay allograft (arrowheads) anchored with Dall-Miles cables that provides added
stability at the junction (long arrow) between the allograft (short arrows) and native femur.







































Figure 7 Osteosarcoma recurrence in the tibia after rotationplasty for femoral primary lesion. (A) Sagittal fast spin-echo
T2-weighted image through the distal femur in a 10-year-old boy demonstrates a heterogeneous, hyperintense tumor (asterisk),
which proved to be pathologically proven osteogenic sarcoma. (B) Positron emission tomography/computed tomography (CT)
image obtained 5 years after rotationplasty for limb salvage procedure shows a focus of increasedmetabolic activity (asterisk) in
the rotated distal tibia near the arthrodesis, corresponding to (C) a lytic destructive lesion (asterisk) on CT. Lesion proved to be
recurrent osteosarcoma, and above-the-knee amputation was subsequently performed.
Figure 8 Desmoid. (A) Axial fast spin-echo T2-weighted fat-suppressed image through the proximal calf demonstrates a large
heterogeneous mass involving the entire posterior compartment, consistent with desmoid tumor. (B) Because of unrelenting
pain despite multiple debridements and chemotherapy, the patient elected to undergo above-the-knee amputation.







































Figure 9 Popliteal stump neuroma. Sagittal T1-weighted
image through the thigh after below-the-knee amputation
shows bulbous enlargement of the distal portion of the
transected popliteal nerve, consistent with terminal stump
neuroma (arrow).
Figure 10 Rectus abdominis rotational myocutaneous flap. (A) Coronal T1-weighted image through the anterior pelvic wall
delineates rotation of the left rectus abdominis muscle from its native position (asterisk) into the left groin. Flap was placed for
soft tissue coverage after synovial sarcoma resection. (B) Schematic drawing of rectus abdominis rotational flap with
preservation of the vascular pedicle (arrow shows rotational direction).
Figure 11 Sarcoma recurrence within rectus myocuta-
neous flap. Axial T1-weighted image through the lower
pelvis in a 72-year-old man displays an intensely enhancing
nodule (arrow) in the left groin myocutaneous flap, which
proved to be recurrent grade 3 undifferentiated pleomorphic
sarcoma.







































(Fig. 15).17 Radiation doses >50 Gy can result in
complete bone necrosis, and lesser doses can make the
irradiated bone more prone to fracture.23,24 Radiation
osteitis occurs in a third to a half of patients receiving
radiation therapy, and abnormal marrow signal has been
reported 9 to 42 months after treatment.17 Cryotherapy
is being used more frequently to treat musculoskeletal
tumors and can also result in marrow necrosis or marrow
edema-like signal changes.18 Bone allografts used for
limb salvage surgery can result in abnormal marrow
signal on MRI due to fat, gelatinous material, and
fibrovascular tissue.18
RADIATION-INDUCED SARCOMAS
Radiation-induced sarcomas are rare and occur in the
soft tissues more than two times more frequently than in
bone.17 Radiation-induced sarcoma of bone is an un-
common sequela that occurs an average of 13 to 14 years
after radiotherapy, with a minimum of a 5-year history of
latency.23,25,26 These aggressive sarcomas tend to de-
velop within or at the margin of the irradiated field, have
Figure 12 ‘‘Muscle texture’’ sign. Sagittal T1-weighted
image through a rotational gastrocnemius flap demonstrates
the presence of linear fat (arrows) between muscle bundles,
indicating there is no underlying soft tissue mass to suggest
tumor recurrence.
Figure 13 Recurrent giant cell tumor. (A) Recurrent giant cell tumor (arrows) in the medial femoral condyle extends along the
cement (asterisk) that was placed after curettage of the original lesion. Intra-articular extension of tumor is seen to better
advantage after arthrography. (B) Sagittal T1-weighted and (C) axial fast spin-echo T2-weighted images in a 39-year-old man
show a larger focus of recurrent giant cell tumor (arrows) extending about the proximal humeral cement (asterisks).







































Figure 14 Tumor recurrence around humeral prosthesis. (A) Sagittal two-dimensional computed tomography reconstructed
image through the humerus shows a pathological fracture through the lytic destructive lesion through the midhumerus, which
proved to be malignant fibrous histiocytoma (MFH). (B) Coronal T1-weighted enhanced magnetic resonance imaging through
the left humerus 2 years after tumor resection and rod fixation shows recurrent MFH with central necrosis and a nodular,
enhancing border (arrows). Susceptibility artifact (asterisks) is from metallic rod.
Figure 15 Radiation changes of the bones. (A) Sagittal T1-weighted image through the lumbosacral spine shows complete
fatty replacement of the sacrum, corresponding to extent of the radiation field. (B) Sagittal fast spin-echo T2-weighted fat-
suppressed image obtained in an 85-year-old woman who was treated 19 months previously with 5040 cGy of external-beam
radiation for leiomyosarcoma of the left medial thigh demonstrates new heterogeneous, hyperintense marrow signal in the
anterior distal femoral medullary canal (arrow). Biopsy was not performed, and subsequent follow-up magnetic resonance
imaging showed no discrete mass and progressive changes consistent with radiation osteitis.







































Figure 16 Synovial sarcoma development after radiation therapy. (A) Positron emission tomography/computed tomography
image through the lower pelvis shows a hypermetabolic focus within an ovoid nodule in the right groin (arrow). (B) Coronal fast
spin-echo T2-weighted fast-suppressed image through this region shows a correlative homogeneous, hyperintense nodule
(arrow). Lesion was biopsied and proved to be synovial sarcoma.
Figure 17 Left humeral and surrounding soft tissue radiation-induced osteogenic sarcoma. (A) Axial T1-weighted and (B) fast
spin-echo T2-weighted fat-suppressed images through the upper arm obtained in an 80-year-old woman who was radiated
18 years previously for immunoblastic lymphoma demonstrate a destructive mass in the proximal humerus with multilobulated
soft tissue extension. Biopsy revealed grade 4/4 osteogenic sarcoma. (C) Anteroposterior radiograph of the arm after resection
of the proximal half of the humerus and placement of a custom humeral arthroplasty.







































a different histology than the original tumor, may
develop in normal bones or ones with preexisting lesions,
and occur in patients with a mean radiation dose of 43 to
64 Gy.23 Ninety percent of radiation-induced sarcomas
are either osteosarcoma or fibrosarcoma, and this sub-
type of osteosarcoma accounts for 5% of all osteogenic
sarcomas.23 Chondrosarcoma, malignant fibrous histio-
cytoma, lymphoma, Ewing’s sarcoma and metastasizing
chondroblastoma are less commonly reported radiation-
induced sarcomas.26 Because radiation-induced sarco-
mas are of a different histology than the original treated
tumor, they tend to have differing MR imaging charac-
teristics from the original tumor. However, most of these
sarcomas will be round or ovoid, and they avidly enhance
after the administration of contrast (Figs. 16 and 17).
Patients with radiation-induced sarcoma may also
present for treatment only after sustaining a pathological
fracture (Fig. 18).
Figure 18 Pathological fracture through radiation-induced malignant fibrous histiocytoma of the right femur. (A) Coronal
T1-weighted and (B) fast spin-echo T2-weighted fat-suppressed images through the proximal femur delineate a pathological
fracture (arrow) through the destructive lesion (asterisk) in the intertrochanteric femur. (C) Intraoperative photograph and (D)
anteroposterior radiograph after resection of the proximal femur show optimal placement of the custom bipolar prosthesis.








































Accurately interpreting the imaging findings of treated
musculoskeletal tumors can be difficult. Because these
patients often have anatomic changes related to surgery
and abnormal MRI signal changes related to radiation
and chemotherapy, the radiologist must obtain relevant
surgical and histology reports and systematically evaluate
all available pre- and postsurgical imaging studies. Crit-
ical assessment of musculoskeletal CTs, MRIs, and PET/
CTs is essential in differentiating normal posttreatment
changes from residual or recurrent tumor. Recurrences
most commonly manifest as discrete ovoid or rounded,
vascular solid nodules on MRI or sonography. However,
exceptions to this rule include nonenhancing lobules of
cartilage in recurrent chondrosarcoma, minimally en-
hancing recurrent myxoid tumors, and hypointense and
infiltrative fibrosarcoma or desmoid tumor simulating
scar tissue. Radiologists must be aware of nontumorous
osseous and soft tissue changes such as seromas and
radiation changes of bone.
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